Quest PharmaTech Inc. QPTFF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -31.04% | 10.33% | -20.87% | 24.71% | -23.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.89% | 8.75% | -27.13% | -3.51% | -13.11% |
| Operating Income | 22.89% | -8.75% | 27.13% | 3.51% | 13.11% |
| Income Before Tax | 206.47% | -71.57% | 305.75% | 2,959.84% | -124.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 206.47% | -71.57% | 305.75% | 2,959.84% | -124.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 206.47% | -71.57% | 305.75% | 2,959.84% | -124.40% |
| EBIT | 22.89% | -8.75% | 27.13% | 3.51% | 13.11% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 200.00% | -72.41% | 307.14% | 2,200.00% | -125.81% |
| Normalized Basic EPS | 0.00% | -- | 325.00% | 514.29% | -155.56% |
| EPS Diluted | 200.00% | -72.41% | 307.14% | 2,200.00% | -125.81% |
| Normalized Diluted EPS | 0.00% | -- | 325.00% | 514.29% | -155.56% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |